High Level Antibody Avidity is Achieved in HIV-Seropositive Recipients of an Inactivated Split Adjuvanted (AS03_A) Influenza Vaccine

Keyphrases

• Influenza Vaccine 100%
• Hemagglutination Inhibition 100%
• Adjuvanted 100%
• Antibody Avidity 100%
• HIV Status 100%
• Avidity Index 50%
• HIV Patients 25%
• Vaccination 16%
• Two-dose 16%
• Vaccine Effectiveness 8%
• Immunization 8%
• Influenza-like Illness 8%
• Influenza Vaccination 8%
• Pandemic Influenza Vaccine 8%
• Vaccine Dose 8%
• Second Dose 8%
• One Dose 8%
• Arepanrix 8%
• Vaccine Immunogenicity 8%
• Immunization Strategy 8%
• Severe Influenza 8%
• Dosing Strategy 8%
• Antibody Titer 8%
• HIV-positive 8%
• Hemagglutination Inhibition Antibody 8%

Immunology and Microbiology

• Influenza Vaccine 100%
• Human Immunodeficiency Virus 100%
• Hemagglutination Inhibition 100%
• Titer 50%
• Vaccine Efficacy 41%
• Vaccination Policy 25%
• Influenza 16%
• Monospecific Antibody 16%
• Antibody Titer 8%
• Vaccine Immunogenicity 8%

Biochemistry, Genetics and Molecular Biology

• Glycogen Synthase Kinase 8%